Ajovy

— THERAPEUTIC CATEGORIES —
  • Migraine and headache

Ajovy Generic Name & Formulations

General Description

Fremanezumab-vfrm 225mg/1.5mL; soln for SC inj; preservative-free.

Pharmacological Class

Calcitonin gene-related peptide (CGRP) receptor antagonist.

How Supplied

Single-dose prefilled syringe—1; Single-dose prefilled autoinjector—1, 3

Manufacturer

Generic Availability

NO

Ajovy Indications

Indications

Prophylaxis of migraine.

Ajovy Dosage and Administration

Adult

Give by SC inj into abdomen, thigh, or upper arm. 225mg monthly or 675mg (given as 3 consecutive 225mg inj) every 3 months.

Children

Not established.

Ajovy Contraindications

Not Applicable

Ajovy Boxed Warnings

Not Applicable

Ajovy Warnings/Precautions

Warnings/Precautions

Consider discontinuing if hypersensitivity reaction occurs. Pregnancy. Nursing mothers.

Ajovy Pharmacokinetics

See Literature

Ajovy Interactions

Not Applicable

Ajovy Adverse Reactions

Adverse Reactions

Inj site reactions (eg, pain, induration, erythema); hypersensitivity reactions.

Ajovy Clinical Trials

See Literature

Ajovy Note

Not Applicable

Ajovy Patient Counseling

See Literature

Images